AIDS

Article	Citations
Safety and efficacy of switching to 4-weekly albuvirtide plus daily dolutegravir in virologically suppressed HIV-1 adults: a 24-week study	130
Factors influencing antiretroviral therapy switching in people with virologically suppressed HIV-1: a cross-sectional multicenter study in France	86
Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxis	82
From pregnancy to beyond: renewed emphasis on comprehensive HIV prevention in South Africa	76
Women with HIV: increased need for reproductive health services to improve health outcomes	66
Psychosocial factors account for a proportion of the difference in cognitive performance between persons with and without HIV	66
Body weight changes in people with HIV starting dolutegravir versus efavirenz-based regimens in a large cohort in rural Tanzania	58
Mitochondrial dysfunction in people with HIV receiving contemporary antiretroviral therapy	40
High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy	39
Cognitive function and mortality among persons aging with HIV and injection drug use	38
Analysis of HIV transmission characteristics and intervention effects in Guangxi based on molecular networks	38
A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin	37
A genetic variation in Fucosyltransferase 8 accelerates HIV-1 disease progression indicating a role for N-glycan fucosylation	37
Amebic liver abscess presenting in a nonendemic region after a 12-year latency in a patient with well controlled HIV infection	36
Risk factors and prognostic significance of anemia in children with HIV infection on antiretroviral therapy	36
Epicardial fat and liver stiffness by acoustic radiation force impulse elastography in people with HIV-1 infection without liver disease	29
The potential impact of new tuberculosis vaccines on the burden of tuberculosis in people with HIV in South Africa	29
Bone density changes in young women in Uganda using tenofovir-based HIV preexposure prophylaxis and depot medroxyprogesterone acetate contraception	29
Strategies for managing weight gain associated with antiretroviral therapy: switch or add?	29
The need to avert emergent resistance to dolutegravir in children and adolescents with HIV	27
Plasma anti-CD4 IgG levels are not associated with poor immune recovery in people with HIV initiating antiretroviral therapy	27
T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa	26
Beyond virologic suppression	26
Long-term persistence of transcriptionally-active “defective” HIV-1 proviruses: Implications for persistent immune activation during antiretroviral therapy	26
HIV viral suppression in children and adolescents 2 years after transition to dolutegravir: a multicentre cohort study	25

Gestational weight gain in persons with HIV in the United States	25
Impacts of intimate partner violence and sexual abuse on antiretroviral adherence among adolescents living with HIV in South Africa	24
The combined effects of age and HIV on the anatomic distribution of cortical and cancellous bone in the femoral neck among men and women	23
Factors associated with insulin resistance in a longitudinal study of Ugandan youth with and without HIV	23
Country of birth is associated with discrepancies in the prescription of two-drug regimens in successfully treated people with HIV in France	22
Extracellular vesicle small noncoding RNAs: a window into pathogenesis and diagnosis	22
Individual and household factors associated with non-disclosure of positive HIV status in a population-based HIV serosurvey	21
Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure – two nationwide, population-based cohort studies	21
The cost-effectiveness of a resilience-based psychosocial intervention for HIV prevention among MSM in India	21
Differential genome-wide associated variants and enriched pathways of electrocardiogram parameters among people with versus without HIV	21
Long-acting cabotegravir and rilpivirine for HIV-1 suppression: switch to 2-monthly dosing after 5 years of daily oral therapy	21
Toward demystifying HIV as a risk factor for coronavirus disease 2019 complications	21
Impact of preexisting nucleos(t)ide reverse transcriptase inhibitor resistance on the effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in treatment experience patients	20
Challenging management of a post-coronavirus disease 2019 invasive Aspergillus sinusitis in a person living with HIV	20
Trans women have worse cardiovascular biomarker profiles than cisgender men independent of hormone use and HIV serostatus	20
Sex differences in cytokine profiles during suppressive antiretroviral therapy	19
A case of primary central nervous system lymphoma in advanced naive HIV-infected patient: the role of antiviral agents	19
Vertical anti-SARS-CoV-2 monoclonal antibody transfer from mothers to HIV-exposed and unexposed infants	19
Good2Go: perceptions and impact of a community-based comprehensive sexual health screening program in San Diego, California	19
Triple trouble: syphilitic neuroretinitis preceding progressive outer retinal necrosis in a HIV-infected man	19
Low-frequency pre-treatment HIV drug resistance: effects on 2-year outcome of first-line efavirenz-based antiretroviral therapy	19
Evaluating the Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe programme, what's worked and what more needs to be done?	18
From policy to practice: uptake of pre-exposure prophylaxis among adolescent girls and young women in United States President's Emergency Plan for AIDS Relief-supported countries, 2017–2020	18
Marked clinical and radiological improvement following pembrolizumab therapy for HIV-associated PML-IRIS	18
Subclinical cardiac disease in children with perinatally acquired HIV is associated with inflammation	17
Patterns of objectively measured physical activity differ between men living with and without HIV	17
A randomized study of intensified antiretroviral treatment monitoring versus standard-of-care for prevention of drug resistance and antiretroviral treatment switch	17
Human herpes virus 8-related illness: still with us	17
Longitudinal characterization of circulating extracellular vesicles and small RNA during simian immunodeficiency virus infection and antiretroviral therapy	17
Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIV	16
Response to comments by Taramasso and colleagues on weight gain stopping/switch rules for antiretroviral clinical trials	16
What's up with the decline in beans? Are there simple tests to identify people with HIV at risk for chronic kidney disease?	16
How the COVID-19 pandemic and the health system's response reduced HIV testing and increased late diagnoses in Mexico	16
Comparison of dolutegravir and efavirenz on depression, anxiety and sleep disorders in pregnant and postpartum women living with HIV	16
Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery	16
Trends in preexposure prophylaxis use among sex partners as reported by persons with HIV – United States, May 2015–June 2020	16
Mediation analysis of chronic kidney disease risk factors using kidney biomarkers in women living with HIV	16
Explaining racial and ethnic disparities in antiretroviral therapy adherence and viral suppression among U.S. men who have sex with men	16
Antiretroviral therapy for HIV and intrahepatic hepatitis C virus replication	15
Social context and tracing household wealth over time in rural Uganda 1994–2018	15
Hepatitis delta in patients hospitalized in Spain (1997–2018)	15
Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs: authors’ reply	15
Use of dietary supplements containing polyvalent cations and antacids among people with HIV and its impact on viral suppression	15
Trends in hospitalizations and deaths in HIV-infected patients in Spain over two decades	15
Women are from venus: implications for diversified sex-based preexposure prophylaxis approaches	15
Bictegravir/emtricitabine/tenofovir alafenamide plus doravirine in highly treatment-experienced men with multidrug-resistant HIV	14
Impact of sub-optimal HIV viral control on activated T cells	14
Key milestones and participant engagement strategies in research with HIV-affected adolescents and young adults from low-to-middle income countries	14
An estimate of excess deaths among people with HIV during the coronavirus disease 2019 pandemic in the United States, 2020	14
Reaching for the ‘first 95’: a cross-country analysis of HIV self-testing in nine countries in sub-Saharan Africa	14

Cost of improved test and treat strategies in Indonesia	14
A prospective 18F-fluorodeoxyglucose positron emission tomography/computed tomography study of the neurometabolic effects in cocaine use and HIV infection	14
High rate of long-term clinical events after antiretroviral therapy resumption in HIV-positive patients exposed to antiretroviral therapy interruption	14
Successful treatment of HIV-associated progressive multifocal leukoencephalopathy with pembrolizumab	13
High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV – but HIV viremia matters?	13
Unmet needs for HIV ancillary care services by healthcare coverage and Ryan White HIV/AIDS program assistance	13
Neutralization sensitivity of genital tract HIV-1: shift in selective milieu shapes the population available to transmit	13
Incidence of lung and human papilloma virus-associated malignancies in HIV-infected patients	13
A triple case series of uveitis caused by HIV, syphilis and tuberculosis coinfection	13
Thrombotic thrombocytopenic purpura (TTP) in Human immunodeficiency virus (HIV) infected patients: New twists on an old disease	13
County-level predictors of retention in care status among people living with HIV in South Carolina from 2010 to 2016: a data-driven approach	13
The barrier functions of crude cervical mucus plugs against HIV-1 infection in the context of cell-free and cell-to-cell transmission	13
Underdetection of pre-existing HIV/AIDS during psychiatric hospitalizations	13
Anal cancer incidence in men with HIV who have sex with men: are black men at higher risk?	13
T-cell activation and B-cell interaction signatures in rectal tissues are associated with HIV replication in ex-vivo model of infection	13
Survival following screening and preemptive antifungal therapy for subclinical cryptococcal disease in advanced HIV infection	13
A moving target: impacts of lowering viral load suppression cutpoints on progress towards HIV epidemic control goals	12
AIDS: changes in leadership	12
Preexposure prophylaxis availability among health facilities participating in the global International epidemiology Databases to Evaluate AIDS (IeDEA) consortium	12
Exposure to doravirine, lamivudine, tenofovir, and raltegravir in a patient with HIV after a Roux-en-Y gastric bypass	12
Viremia controls Env-specific antibody-secreting cell responses in simian immunodeficiency virus infected macaques pre and post-antiretroviral therapy	12
Hepatitis B reactivation after tenofovir withdrawal in an HIV-infected patient with history of cured hepatitis B virus infection and poor immunological status	12
Intersectionality-informed analysis of durable viral suppression disparities in people with HIV	12
Optimizing behavioral and pharmacological smoking cessation interventions among people with HIV: comment	12
Quantifying the association of individual-level characteristics with disparities in kidney transplant waitlist addition among people with HIV	12
Is the GLP-1 receptor agonist, semaglutide, a good option for weight loss in persons with HIV?	12
Growing data for recycling tenofovir and lamivudine with dolutegravir as empiric second-line antiretroviral therapy in resource-limited settings	12
Neurologic infections in people with HIV: shifting epidemiological and clinical patterns	12
HIV drug resistance monitoring in the era of dolutegravir and injectable long-acting cabotegravir in resource-limited settings	12
A note of thanks to our reviewers	12
Bringing back condoms	12
Outcomes of discordant HIV screening test results at a southern academic medical center	12
Prevalence of HIV testing among black and white transgender adults, 2016–2019	12
Using serial cross-sectional surveys to create a retrospective nested cohort to determine HIV incidence from 20 US cities	12
Progress towards achieving national goals for improved quality of life among cis-gender Black women with HIV	11
Racial, gender, and psychosocial disparities in viral suppression trends among people receiving coordinated HIV care in Los Angeles County	11
Quantifying missed opportunities for tuberculosis among people with HIV in the US President's Emergency Plan for AIDS Relief	11
Virtual case management: a differentiated approach to HIV prevention, treatment, and care	11
Gut microbiota and plasma metabolites associated with bone mineral density in women with or at risk of HIV infection	11
Estimates of HIV testing at visits to United States emergency departments	11
Incidence, clearance, and factors associated with anal human papilloma virus infection among men with HIV	11
False-positive HIV screening tests during the COVID-19 pandemic, a passing trend?	11
The effect of a social network-based intervention on adherence to HIV pre-exposure prophylaxis and HIV viral suppression among Kenyan fishermen	11
Lower endoscopy, early-onset, and average-onset colon cancer among Medicaid beneficiaries with and without HIV	11
Weight loss associated with semaglutide treatment among people with HIV	11
Life expectancy of people with HIV on antiretroviral therapy in Spain	11
Lower aids-related hospitalizations in women living with HIV multidrug resistance	10
Cardiovascular health among persons with HIV without existing atherosclerotic cardiovascular disease	10
Monocyte phenotype and extracellular vesicles in HIV-1, HIV-2, and HIV-1/2 dual infection	10
Lipidome association with vascular disease and inflammation in HIV+ Ugandan children	10
Improving adherence to daily preexposure prophylaxis among MSM in Amsterdam by providing feedback via a mobile application	10
The clinical utility of three frailty measures in identifying HIV-associated neurocognitive disorders	10
Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV	10
Systematic review and quantitative and qualitative comparative analysis of interventions to address HIV-related stigma and discrimination	10
Application of machine-learning techniques in classification of HIV medical care status for people living with HIV in South Carolina	10
Pulse wave velocity in early-treated children living with perinatal HIV infection is similar to uninfected children	10
I would but I cannot, I can but I do not want: unmet needs of people with HIV in the long-acting era	10
A systematic review of qualitative research on recently acquired HIV	10
Leveraging emergency care to reach key populations for ‘the last mile’ in HIV programming: a waiting opportunity	10
Elimination of perinatal transmission of hepatitis B: lessons learned from women with HIV-HBV coinfection	10
Improvement in CD4 count among people with HIV in New York City, 2007-2021: a serial cross-sectional analysis	10
Natural killer cells during acute HIV-1 infection: clues for HIV-1 prevention and therapy	10
HIV accelerates clonal hematopoiesis and cardiovascular aging	10
David Katzenstein and James Hakim—In Memoriam	10
Ex-vivo rectal tissue infection with HIV-1 to assess time to protection following oral preexposure prophylaxis with tenofovir disoproxil/emtricitabine	10
Advanced HIV disease and engagement in care among patients on antiretroviral therapy in South Africa: results from a multi-state model	9
Postural instability in HIV infection: relation to central and peripheral nervous system markers	9
Associations between efavirenz concentrations, pharmacogenetics and neurocognitive performance in people living with HIV in Nigeria	9
Maternal HIV infection and antiretroviral exposure during pregnancy in fetuses and newborns: when solving one problem opens up a Pandora's box of new conundrums	9
Utilizing electronic health record data to understand comorbidity burden among people living with HIV: a machine learning approach	9
The effect of an HIV preexposure prophylaxis panel management strategy to increase preexposure prophylaxis prescriptions	9
A new frontier in HIV care: the predictive power of renal biomarkers on heart health	9
Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 switching to long-acting cabotegravir and rilpivirine	9
Impact of rilpivirine cross-resistance on long-acting cabotegravir-rilpivirine in low and middle-income countries	9
Maternal breastfeeding and education impact infant growth and development more than in-utero HIV/antiretroviral therapy exposure in context of universal antiretroviral therapy	9
Association of envelope-specific B-cell differentiation and viral selective pressure signatures in HIV-1 CRF01_AE infection	9
Associations between social determinants of health and comorbidity and multimorbidity in people of black ethnicities with HIV	9
Can simplified antiretroviral drug combination therapies resist resistance?	9
Dramatic improvement of MRI abnormalities of HIV encephalopathy after suppressive antiretroviral therapy	9
Changing costs of preexposure prophylaxis may undermine efforts to curb HIV infection rates	9

Durability of switched therapy after failure of WHO-recommended antiretroviral therapy regimens in a resource-limited setting	9
HIV transmission among acutely infected participants of a Dutch cohort study 2015–2021 is not associated with large, clustered outbreaks	9
Synergy between low BMI and hyperglycemia at baseline increases tuberculosis incidence among people living with HIV	9
Examining incidence of diabetes in people with HIV: tracking the shift in traditional and HIV-related risk factors	9
HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activity	9
HIV in the Russian Federation: mortality, prevalence, risk factors, and current understanding of sexual transmission	9
Atazanavir-induced lithiasis evidenced several years after drug discontinuation	8
Outcomes of a policy to prioritize populations with expected healthcare barriers for subsidized preexposure prophylaxis care in Amsterdam, the Netherlands	8
Differences in HIV clinical outcomes amongst heterosexuals in the United Kingdom by ethnicity	8
Keeping up with Streptococcus pneumoniae in children living with HIV: Erratum	8
Causes of death in HIV-infected and HIV-uninfected children aged under-five years in western Kenya	8
Keeping up with Streptococcus pneumoniae in children living with HIV	8
Effectiveness of topical cidofovir for treatment of refractory anal high-grade squamous intraepithelial lesion (HSIL)	8
The association of exposure to DREAMS on sexually acquiring or transmitting HIV amongst adolescent girls and young women living in rural South Africa	8
Different effects of the companion antiretroviral drugs on dolutegravir trough concentrations	8
Legacy effect on neuropsychological function in HIV-infected men on combination antiretroviral therapy	8
Using computer-assisted content analysis to advance anal dysplasia natural history research	8
Deconvoluting the contribution of antiretroviral choice in weight gain	8
Effect of HIV on respiratory symptoms, health status, and exertional capacity: a systematic review and meta-analysis	8
Dolutegravir-induced neural tube defects in mice are folate responsive: Erratum	8
HIV-1 gp120 amplifies astrocyte elevated gene-1 activity to compromise the integrity of the outer blood–retinal barrier	8
Patients with HIV and cirrhosis: the risk for hepatocellular carcinoma after direct-acting antivirals for hepatitis C virus	8
Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment	8
Sexual behaviours and risk with women in MSM in sub-Saharan Africa	8
Dosing lamivudine or emtricitabine in renal impairment: new data confirm it's time for updated guidance!	8
Multimorbidity networks associated with frailty among middle-aged and older people with HIV	8
Mpox infection in people living with HIV	8
Real world use of dolutegravir two drug regimens	8
Incidence of HIV-positive admission and inpatient mortality in Malawi (2012–2019)	8
Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens	8
Fibrocavitary disease caused by Mycobacterium chimaera in a patient with HIV	8
Association between inflammatory biomarker profiles and cardiovascular risk in individuals with and without HIV	8
Immediate virological failure with intramuscular cabotegravir–rilpivirine in a patient long suppressed with dolutegravir–rilpivirine	8
Microfinance, retention in care, and mortality among patients enrolled in HIV care in East Africa	8
Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals	8
Incident diabetes in course of antiretroviral therapy	8
Provision of HIV preexposure prophylaxis to female patients seeking family planning services in the United States	8
Changes in short-term (in-ICU and in-hospital) mortality following Intensive Care Unit admission in adults Living with HIV: 2000–2019	8
Dolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV	8
Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy – naive adults with HIV-1 infection	8
Treatment outcomes amongst older people with HIV infection receiving antiretroviral therapy	8
The predicted risk of adverse pregnancy outcomes as a result of treatment-associated obesity in a hypothetical population receiving tenofovir alafenamide/emtricitabine/dolutegravir, tenofovir disoprox	8
Mosaic chromosomal alterations detected in men living with HIV and the relationship to non-Hodgkin lymphoma	8
Association between tight junction proteins and cognitive performance in untreated persons with HIV	7
Trends in HIV testing and HIV stage at diagnosis among people newly diagnosed with HIV	7
The impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy	7
Highly active antiretroviral therapy-related effects on morphological connectivity in HIV	7
Impacts of religious liberty court case outcomes on pre-exposure prophylaxis accessibility for Medicaid beneficiaries	7
Use of long-acting cabotegravir + rilpivirine during hemodialysis and solid organ transplantation	7
Impact of short message service and peer navigation on linkage to care and antiretroviral therapy initiation in South Africa	7
Using a machine learning approach to explore predictors of healthcare visits as missed opportunities for HIV diagnosis	7
Association between substance use disorders and sustained viral suppression: a longitudinal analysis among people with HIV in South Carolina	7
A decision analytics model to optimize investment in interventions targeting the HIV preexposure prophylaxis cascade of care	7
Is tenofovir disoproxil fumarate associated with weight loss?	7
Infant postnatal prophylaxis following maternal viraemia during breastfeeding	7
Elevated stress-responsive biomarkers are associated with HIV acquisition in young women in rural South Africa	7
A randomized trial of ‘fresh start’ text messaging to improve return to care in people with HIV who missed appointments in South Africa	7
The impact of past HIV interventions and diagnosis gaps on new HIV acquisitions, transmissions, and HIV-related deaths in Côte d’Ivoire, Mali, and Senegal	7
Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV	7
HIV viral load monitoring during monkeypox virus infection among people with HIV	7
Leveraging social networks for identification of people with HIV who are virally unsuppressed	7
Cardiovascular outcomes among persons with HIV and nonalcoholic fatty liver disease	7
Evolving relationship between HIV infection and inflammatory bowel disease adds layer of complexity to HIV management	7
Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection	7
Modelling the impact of HIV and hepatitis C virus prevention and treatment interventions among people who inject drugs in Kenya	7
Brain RNA profiling highlights multiple disease pathways in persons with HIV-associated neurocognitive disorder	7
Dolutegravir-containing HIV therapy reversibly alters mitochondrial health and morphology in cultured human fibroblasts and peripheral blood mononuclear cells	7
Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV	7
Regional variation in weight change after the transition to dolutegravir in Uganda and South Africa	7
Performance of patient-collected dried blood specimens for HIV-1 viral load testing in South Africa	7
Proinflammatory and cardiovascular biomarkers are associated with echocardiographic abnormalities in children with HIV taking antiretroviral therapy	7
The prevalence of mental health disorders in people with HIV and the effects on the HIV care continuum	7
Alterations in glutamate, arginine, and energy metabolism characterize cerebrospinal fluid and plasma metabolome of persons with HIV-associated dementia	7
Response to correspondence to ‘No long-term effect of past Pneumocystis jirovecii pneumonia on pulmonary function in people with HIV’	7
Preventing SARS-CoV-2 infection and its severe outcomes in HIV-infected people	7
Rapid antiretroviral therapy initiation and its effect on treatment response in MSM in West Africa	7
Differential systemic immune-inflammation index levels in people with and without HIV infection	7
Using molecular epidemiology to trace the history of the injection-related HIV epidemic in New York City, 1985–2019	7
Cumulative HIV viral load and lower CD4+ cell count are associated with incident venous thromboembolism in people with HIV	7
Intersectional stigmas are associated with lower viral suppression rates and antiretroviral therapy adherence among women living with HIV	7
Mitigating cognitive impairment in people with HIV by targeting potential impacts of toxoplasmic infection	7
The construction of a novel supplementary diagnostic model for patients with indeterminate HIV infection	7
Prevalence and outcomes of pregnancies in women with HIV over a 20-year period	6
Community-based peer-led HIV/sexually transmitted infection testing services in Sydney for gay and bisexual men captured an eighth of new HIV diagnoses in New South Wales, Australia	6
Severe coronavirus disease 2019 in a patient with HIV-2 infection	6
Antibody neutralization capacity after COVID-19 vaccination in people with HIV (CIHR Canadian HIV trials network 328)	6
Global progress and gaps in tuberculosis screening and treatment among people with HIV: experience from 32 countries	6
Authors’ response to ‘Optimizing behavioral and pharmacological smoking cessation interventions among people with HIV: comment’	6
Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age	6
Tryptophan metabolism, gut microbiota, and carotid artery plaque in women with and without HIV infection	6
Soluble biomarkers associated with chronic lung disease in older children and adolescents with perinatal HIV infection	6
Applying a machine learning modelling framework to predict delayed linkage to care in patients newly diagnosed with HIV in Mecklenburg County, North Carolina, USA	6
Hepatitis C virus infection and cardiac dysfunction in women	6
Identifying influential neighbors in social networks and venue affiliations among young MSM: a data science approach to predict HIV infection	6
Baseline renal function predicts mortality in adolescents commenced on HIV antiretroviral therapy	6